Breztri Aerosphere · DIN 02518058 · 160 mcg & 7.2 mcg & 5 mcg/Act · Metered Dose inhaler, 120 doses
Limited Use, Reason for Use code 638 requiredMarketed · checked November 18, 2026
StatusLimited Use, Reason for Use code 638 required
Write on scriptReason for Use code 638 (criteria below)
Patient paysIf the Reason for Use code is written and the criteria are met, ODB 65 and over pays:
• ODB senior: $100/program-year deductible
• Then up to $6.11 per prescription
• Or, if enrolled in the Seniors Co-Payment Program (income-tested; individual net income below $25,480 for Aug 2026–Jul 2027): no deductible, up to $2 per prescription
If the criteria are not met, ODB does not pay this product under Limited Use. [Limited Use benefit, Formulary flag]
Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.
Ontario Limited Use criteria, code 638
Reason for Use code 638
For the long-term maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema and to reduce exacerbations of COPD in patients with a history of exacerbations in patients who require a combination of an inhaled corticosteroid (ICS), long-acting muscarinic antagonist (LAMA), and a long-acting beta2-adrenergic agonist (LABA).
Coverage limit:
LU Authorization Period: Indefinite
No interchangeable product listed in the Ontario extract
Breztri Aerosphere · DIN 02518058
Manufacturer: AstraZeneca; listing date 2022-10-31
Health Canada: Marketed since 2024-01-05 · brand BREZTRI AEROSPHERE · ATC R03AL11 FORMOTEROL, GLYCOPYRRONIUM BROMIDE AND BUDESONIDE · form Aerosol (metered-dose) · route Inhalation · ingredients BUDESONIDE 160 MCG/ACT, GLYCOPYRRONIUM (GLYCOPYRROLATE) 7.2 MCG/ACT, FORMOTEROL FUMARATE DIHYDRATE 5 MCG/ACT · company Astrazeneca canada inc · schedule Prescription
Breztri Aerosphere: Formulary list price $127.00 per unit (the source does not state the unit; exact figure $127.0000). What the ministry pays, not the patient.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02518058)
Source record
DIN 02518058: Breztri Aerosphere
Raw flags: sec12=Y, sec3=Y
Item: 121200121; group id 221; item number 0399; lccId 00385; manufacturer id AZC
Source form: Metered Dose Inh-120 Dose Pk; strength: 160mcg & 7.2mcg & 5mcg/Act
Recorded listing: Limited Use: paid only with a Reason for Use code and the criteria below
Source prices (unrounded): $127.0000; ministry $127.0000
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02518058
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=100738
Shortage status: not checked (no credentials)